ANDREA BENAVIDEZ: Open Payments
NPI 1154807725 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$799 in 54 payments from 12 companies in 2025. Trend: 2023 $727 · 2024 $813 · 2025 $799
Food & beverage: $799
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $243 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $143 |
| Novo Nordisk Inc | 3 | $76 |
| PFIZER INC. | 4 | $76 |
| Lilly USA, LLC | 3 | $65 |
| Lundbeck LLC | 2 | $55 |
| Exeltis, USA Inc. | 2 | $40 |
| E.R. Squibb & Sons, L.L.C. | 1 | $28 |
| Exact Sciences Corporation | 1 | $20 |
| JAZZ PHARMACEUTICALS INC. | 1 | $20 |
Products named: CAPLYTA, QULIPTA, NURTEC ODT, MOUNJARO, VRAYLAR, REXULTI, Wegovy, UBRELVY.
Industry payments across NM — which companies pay providers there.
